A major advance in cancer study is arising with the use of mini-antibodies to reactivate damaged p53. This essential malignant suppressor protein is frequently inactivated in several types of malignancies, causing https://thegreatbookmark.com/story21956947/nanobodies-reactivate-tumor-suppressor-p53-new-new-hope-for-cancer-management